NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Up 250.8% in January

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a large increase in short interest in January. As of January 15th, there was short interest totaling 1,305 shares, an increase of 250.8% from the December 31st total of 372 shares. Based on an average trading volume of 9,975 shares, the days-to-cover ratio is presently 0.1 days. Based on an average trading volume of 9,975 shares, the days-to-cover ratio is presently 0.1 days.

NRx Pharmaceuticals Price Performance

NRx Pharmaceuticals stock traded down $0.00 during mid-day trading on Friday, reaching $0.06. 200 shares of the company’s stock were exchanged, compared to its average volume of 10,930. NRx Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $0.25. The company has a fifty day moving average of $0.07 and a 200-day moving average of $0.09.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc is a clinical?stage biopharmaceutical company focused on the development of novel therapies for neuropsychiatric and neurodegenerative disorders. The company’s research pipeline includes small?molecule candidates designed to address underlying pathophysiological mechanisms implicated in conditions such as Rett syndrome, Alzheimer’s disease and Long COVID. Leveraging a proprietary formulation and delivery approach, NRx seeks to advance compounds that have demonstrated safety in prior studies toward new indications with significant unmet medical need.

Among its lead programs, NRx is developing NP-120 (sarizotan) for the treatment of Rett syndrome, a rare genetic disorder that impacts brain development in young girls.